World Peptide Foundation · Films & references
Peptides in 2TM
Short journeys through peptide discovery, the people behind the science, and what happens inside the body. Choose a peptide or follow one collection.
34 completed films · 8 collections · Captions, transcripts & original sources
Choose a collection
34 films available
Metabolic & Weight Health
17 films available

Exenatide
From a Gila monster peptide to a diabetes medicine: meet exendin-4, follow the development of exenatide, and explore GLP-1 receptor signaling.
Watch film & explore the research →

Liraglutide
A short-lived hormone, a Danish discovery team, and a design that extended the signal. Explore liraglutide’s development, albumin binding, and the distinction between Victoza and Saxenda.
Watch film & explore the research →

Lixisenatide
From Zealand Pharma’s Danish development work to the response after a meal. Follow lixisenatide through GLP-1 receptor signaling, gastric emptying, and its combination with insulin glargine.
Watch film & explore the research →

Albiglutide
From Human Genome Sciences in Maryland to a weekly GLP-1 medicine. Explore albumin fusion, Tanzeum and Eperzan, and the cardiovascular evidence that outlasted the medicine’s commercial availability.
Watch film & explore the research →

Dulaglutide
Lilly’s Trulicity took a different molecular approach to a once-weekly GLP-1 medicine. Explore its antibody-derived scaffold, the development history, and what the international REWIND trial found.
Watch film & explore the research →

Semaglutide
From Novo Nordisk’s Danish research to Ozempic, Rybelsus and Wegovy. Explore molecular engineering, the oral absorption breakthrough, and the human evidence behind the headlines.
Watch film & explore the research →

Tirzepatide
From Lilly’s discovery work to Mounjaro and Zepbound. Follow the dual GIP/GLP-1 receptor design, tissue-to-circulation journey and human trial evidence, with regional labels clearly distinguished.
Watch film & explore the research →

Retatrutide
Explore Lilly’s discovery work, three receptor targets, experimental molecular models and human trial evidence. Retatrutide remains investigational; research geography and medicine approval are distinct.
Watch film & explore the research →

Amylin & Pramlintide
The amylin branch begins with the 1987 discovery papers, three amino-acid changes, the 2002 human trial and the 2005 U.S. Symlin approval. Explore a complementary meal-time signal, its clinical evidence and important safety context.
Watch film & explore the research →

Cagrilintide
From Novo Nordisk’s Danish development team to human trials and experimental receptor structures. Explore cagrilintide as one investigational peptide, distinct from the two-medicine combination CagriSema.
Watch film & explore the research →

CagriSema
Cagrilintide and semaglutide remain two separate ingredients in one investigational combination. Follow the development story, complementary receptor pathways, REDEFINE 1 results, and the direct REDEFINE 4 comparison—keeping trial populations and estimates distinct.
Watch film & explore the research →

Zenagamtide / Amycretin
Follow zenagamtide, previously called amycretin, from Novo Nordisk’s development and early oral research to separate oral and injectable phase 2 diabetes analyses. Explore one engineered peptide, complementary receptor signals, and the evidence behind the HbA1c results.
Watch film & explore the research →

Eloralintide
Explore Eli Lilly’s eloralintide, the meaning of receptor selectivity, and published 48-week single-agent obesity results. Laboratory potency, clinical weight change, tolerability, and combination research each retain their own context.
Watch film & explore the research →

Survodutide
Follow Boehringer Ingelheim and Zealand Pharma’s survodutide through separate weight and MRI liver-fat studies. Examine the populations, treatment-discontinuation analyses, safety findings, and limits of each measurement.
Watch film & explore the research →

Mazdutide
The group finale follows Lilly-originated mazdutide through Innovent’s development in China, GLORY-1 weight results, and separate China approval milestones. Connect each claim to its population, measurement, safety record, and jurisdiction.
Watch film & explore the research →

Insulin & Glucagon
A Toronto breakthrough and a Rochester experiment revealed two hormones that help regulate blood sugar after meals and between them.
Watch film & explore the research →

Somatostatin
Insulin and glucagon help regulate blood sugar. A third peptide hormone helps regulate the cells that release them.
Watch film & explore the research →
Repair, Recovery & Tissue Health
2 films available

BPC-157
Explore experimental BPC-157 research in tissue recovery and the digestive tract, keeping animal findings, human reports, and their limitations distinct.
Watch film & explore the research →

Thymosin beta-4 & TB-500
Follow molecular identity into a defined corneal-healing study, then examine how preparation, population, and measured outcomes shape an evidence claim.
Watch film & explore the research →
Growth & Hormonal Signaling
5 films available

Tesamorelin
Follow tesamorelin from a modified GHRH signal to a CT-based visceral-fat endpoint, keeping the studied population, approved use, and safety context in view.
Watch film & explore the research →

CJC-1295
Follow CJC-1295 from a biotechnology challenge in Montreal to an albumin-binding growth hormone-releasing hormone analog, early healthy-adult hormone data, and what those findings do not establish.
Watch film & explore the research →

Ipamorelin
Follow ipamorelin from Novo Nordisk's 1998 Danish research to ghrelin-receptor signaling, early human hormone measurements and a randomized bowel-recovery trial. Explore what these findings establish and which health claims remain unanswered.
Watch film & explore the research →

Sermorelin
A fragment of the brain’s growth hormone signal gave clinicians a way to test the pituitary’s response and study growth in children.
Watch film & explore the research →

GHRH
A pancreatic tumor that caused acromegaly led researchers to a hormone that begins in the brain.
Watch film & explore the research →
Immune Defense & Inflammation
2 films available

Thymosin alpha-1
Meet a thymus-derived immune signal, then follow the question from dendritic-cell biology to a corrected human sepsis trial.
Watch film & explore the research →

KPV
Follow KPV, a three-amino-acid fragment of alpha-MSH, from a 1989 Dallas study to PepT1 transport and mouse colitis research, and see what preclinical findings do not establish.
Watch film & explore the research →
Brain, Pain & Neuropeptides
2 films available

Semax
Meet Semax’s Moscow developers, follow its history of medical use, then examine its molecular design and human evidence.
Watch film & explore the research →

Selank
Selank connects immune biology and brain signaling. See what the studies examined and what remains unknown.
Watch film & explore the research →
Skin, Hair & Pigmentation
1 film available
Reproductive & Sexual Health
2 films available

PT-141
From melanocortin research to the 2019 FDA approval of Vyleesi: follow PT-141 (bremelanotide) through early studies, two phase three trials and the safety limits of its approved use.
Watch film & explore the research →

Kisspeptin
From a cancer-research gene discovered in Hershey to puberty, fertility and sexual signaling: follow kisspeptin from the 1996 KISS1 report to early human studies, and what they do not yet establish.
Watch film & explore the research →
Mitochondria & Aging Research
3 films available

MOTS-c
From its USC discovery to cellular energy signaling and mouse studies of insulin sensitivity and physical performance.
Watch film & explore the research →

Humanin
From a 2001 discovery in Tokyo to experiments on programmed cell death, follow Humanin through nerve cells, worms, mice, and human blood samples. See what each study measured and what remains open.
Watch film & explore the research →

SS-31 (Elamipretide)
Elamipretide, also known as SS‑31, is a peptide studied for its effects on mitochondria. The sources distinguish a short-term laboratory measurement in older adults from the evidence and U.S. approval for Barth syndrome.
Watch film & explore the research →
